|
E2F8 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.801200E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.155600E-01 |
| Normal-vs-Stage2 |
3.358400E-01 |
| Normal-vs-Stage3 |
9.826200E-01 |
| Normal-vs-Stage4 |
4.603800E-01 |
| Stage1-vs-Stage2 |
2.520000E-03 |
| Stage1-vs-Stage3 |
2.608000E-01 |
| Stage1-vs-Stage4 |
5.990800E-01 |
| Stage2-vs-Stage3 |
6.198200E-02 |
| Stage2-vs-Stage4 |
2.043500E-02 |
| Stage3-vs-Stage4 |
2.657800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.445800E-01 |
| Normal-vs-AfricanAmerican |
9.324600E-01 |
| Normal-vs-Asian |
9.436200E-01 |
| Caucasian-vs-AfricanAmerican |
2.975000E-01 |
| Caucasian-vs-Asian |
3.340400E-01 |
| AfricanAmerican-vs-Asian |
9.837200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.480600E-01 |
| Normal-vs-Female |
8.403800E-01 |
| Male-vs-Female |
5.515600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.266800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.017800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.737200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.493400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.602260E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.576000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.660400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.501650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.680400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.104000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.926000E-01 |
| Classical-VS-Follicular |
3.389700E-04 |
| Classical-VS-Other |
3.518000E-02 |
| Classical-VS-Normal |
4.988600E-01 |
| Tall-VS-Follicular |
2.636300E-02 |
| Tall-VS-Other |
7.502000E-02 |
| Tall-VS-Normal |
5.607200E-01 |
| Follicular-VS-Other |
9.374000E-01 |
| Follicular-VS-Normal |
3.919400E-01 |
| Other-VS-Normal |
4.010600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.426400E-01 |
| Normal-vs-N1 |
7.177200E-01 |
| N0-vs-N1 |
4.746400E-01 |
|
|
